tiprankstipranks
Stoke Therapeutics appoints Jason Hoitt as Chief Commercial Officer
PremiumThe FlyStoke Therapeutics appoints Jason Hoitt as Chief Commercial Officer
3M ago
Stoke Stock (NASDAQ:STOK) Gains on Drug Update; Is There More Upside Left?
PremiumMarket News
Stoke Stock (NASDAQ:STOK) Gains on Drug Update; Is There More Upside Left?
4M ago
Stoke Therapeutics Launches Public Offering for Clinical Development
PremiumCompany Announcements
Stoke Therapeutics Launches Public Offering for Clinical Development
4M ago
Stoke Therapeutics price target raised to $22 from $14 at Needham
PremiumThe FlyStoke Therapeutics price target raised to $22 from $14 at Needham
4M ago
Stoke Therapeutics price target raised to $21 from $18 at Canaccord
PremiumThe Fly
Stoke Therapeutics price target raised to $21 from $18 at Canaccord
4M ago
Stoke Therapeutics reports Q4 EPS (60c), consensus (63c)
PremiumThe Fly
Stoke Therapeutics reports Q4 EPS (60c), consensus (63c)
4M ago
Stoke Therapeutics reinstated with Neutral from Overweight at JPMorgan
PremiumThe FlyStoke Therapeutics reinstated with Neutral from Overweight at JPMorgan
8M ago
Short Report: Bears scale back on Celsius after blowout earnings
PremiumThe Fly
Short Report: Bears scale back on Celsius after blowout earnings
8M ago
Stoke Therapeutics reports Q3 EPS (55c), consensus (63c)
PremiumThe Fly
Stoke Therapeutics reports Q3 EPS (55c), consensus (63c)
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100